← Evidence map

ReviewInflammopharmacology2026

Rewiring the psoriasis-metabolism axis: therapeutic potential of saroglitazar beyond PPAR modulation.

Kanika Vashisht et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42789217